Releases

Media coverage

Newsletter

Subscribe to our newsletter

Oct 11, 2011
ICAAC 2011
May 26, 2011
Successful Proof of Concept for topical antimicrobial drug Lytixar™ (LTX-109)
Dec 23, 2010
Lytix Biopharma closes successful shares emission | Lytix Biopharma gjennomfører vellykket emisjon
Dec 6, 2010
Lytix Biopharma and KAEL–GemVax announce first patient treated in clinical trial to combine LTX-315 and GV1001 cancer vaccine immunotherapy
Nov 30, 2010
Lytix Biopharma emisjon- Tid og sted for investorpresentasjoner
Sep 1, 2010
Lytix Biopharma AS announces approval by Hungarian authorities and ethics committee to start Phase IIa clinical trial with Lytixar™ (LTX-109) in Gram positive skin infections
Jun 9, 2010
Lytix Biopharma and KAEL–GemVax announce approval of joint clinical trial to combine LTX-315 and GV1001 cancer vaccine immunotherapy
May 20, 2010
Lytix Biopharma AS announces regulatory approval by Swedish authorities to commence Phase I/IIa clinical trial with Lytixar™ (LTX-109) in MRSA
May 20, 2010
Lytix Biopharma AS update on phase I progress with Oncopore™ for solid tumours
May 4, 2010
Lytix Biopharma AS to hold General Assembly of Shareholders on 4th June 2010
Dec 14, 2009
Lytix Biopharma AS announces regulatory approval by Norwegian and Swedish authorities to commence Phase I clinical trial of OncoporeTM (LTX-315) in cancer
Sep 23, 2009
Lytix Biopharma presented new data on antimicrobial drug LytixarTM (LTX-109) at ICAAC
Aug 19, 2009
Lytix Biopharma announces start of dosing in Phase I trial
Jun 18, 2009
Lytix Biopharma and KAEL–GemVax announce joint clinical trial to combine LTX-315 and GV1001 cancer immunotherapy
Jun 2, 2009
Additional funding through shares emission and warrant scheme
Mar 24, 2009
Additional funding through shares emission and warrant scheme
Feb 26, 2009
Lytix Biopharma to expand team of drug development professionals
Jan 21, 2009
Lytix Biopharma closes successful funding round


Inventors and founders of Lytix Biopharma in NRK's Schrödingers Katt. Watch the programme in Norwegian.